Two new developments in kidney cancer treatments
Studies suggest there are better treatment options than sunitinib for…
Studies suggest there are better treatment options than sunitinib for kidney cancers; cabozantinib in metastatic papillary kidney cancer and lenvatinib/pembrolizumab for renal cell carcinoma.